Dorman Products (DORM) Misses Q4 EPS by 2c, Revenue Beats, Offers Guidance

Dorman Products (NASDAQ: DORM) reported Q4 EPS of $1.33, $0.02 worse than the analyst estimate of $1.35. Revenue for the quarter came in at $398.2 million versus the consensus estimate of $367.45 million.

GUIDANCE:

Dorman Products sees FY2022 EPS of $5.35-$5.55, versus the consensus of $5.42.

• For fiscal 2022, the Company expects net sales growth of 19%-22%, diluted EPS of $4.94 to $5.14, and adjusted diluted EPS* of $5.35 to $5.55.

For earnings history and earnings-related data on Dorman Products (DORM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance